PDL BioPharma, Inc. Income Tax Provision

Income Tax Provision of PDLI for past 10 years: annual, quarterly and twelve month trailing (TTM) including Income Tax Provision growth rates and interactive chart. The actual income tax expense for the applicable year.


Highlights and Quick Summary

  • Income Tax Provision for the quarter ending June 29, 2020 was $-1.08 Million (a -92.56% decrease compared to previous quarter)
  • Year-over-year quarterly Income Tax Provision decreased by -44.6%
  • Annual Income Tax Provision for 2019 was $-3.05 Million (a -123.57% decrease from previous year)
  • Annual Income Tax Provision for 2018 was $12.9 Million (a -82.48% decrease from previous year)
  • Annual Income Tax Provision for 2017 was $73.8 Million (a 61.51% increase from previous year)
  • Twelve month Income Tax Provision ending June 29, 2020 was $-15.2 Million (a -8.98% decrease compared to previous quarter)
  • Twelve month trailing Income Tax Provision decreased by -239.03% year-over-year
Trailing Income Tax Provision for the last four month:
29 Jun '20 30 Mar '20 30 Dec '19 29 Sep '19
$-15.2 Million $-16.7 Million $-3.05 Million $10.9 Million
Visit stockrow.com/PDLI for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow statement with 10 years of data, and state-of-the-art screener.

Historical Income Tax Provision of PDL BioPharma, Inc.

Most recent Income Tax Provisionof PDLI including historical data for past 10 years.

Interactive Chart of Income Tax Provision of PDL BioPharma, Inc.

PDL BioPharma, Inc. Income Tax Provision for the past 10 Years (both Annual and Quarterly)

(All values are in $ million)

Year Q1 Q2 Q3 Q4 Fiscal Year
2020 $-1.08 $-14.47
2019 $2.32 $-1.94 $-2.58 $-0.85 $-3.05
2018 $16.28 $9.9 $-14.27 $1.02 $12.94
2017 $8.65 $4.76 $53.87 $6.55 $73.83
2016 $-4.3 $14.4 $2.66 $32.95 $45.71
2015 $62.14 $40.9 $45.3 $49.02 $197.34
2014 $34.95 $47.36 $54.0 $42.72 $179.03
2013 $36.35 $29.96 $42.0 $29.03 $137.35
2012 $27.68 $26.36 $39.81 $21.61 $115.46
2011 $21.01 $25.02 $37.98 $24.03 $108.04
2010 $-12.32 $23.03 $33.59 $58.5

Business Profile of PDL BioPharma, Inc.

Sector: Other
Industry: Other
PDL BioPharma, Inc. manages various patents in the United States and internationally. The company's patents cover humanization of antibodies. It also offers notes and other long-term receivables services, as well as engages in the equity investment activities. The company was formerly known as Protein Design Labs, Inc. and changed its name to PDL BioPharma, Inc. in 2006. PDL BioPharma, Inc. was founded in 1986 and is headquartered in Incline Village, Nevada.